120 Participants Needed

High-Protein Nutrition for Heart Failure-related Muscle Wasting

(ASTRID-HF Trial)

Recruiting at 1 trial location
AR
Overseen ByAmanda R Vest, MBBS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Tufts Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether high-protein nutrition can prevent muscle wasting in people with heart failure, specifically those with reduced ejection fraction. Participants will be divided into three groups: one with no protein supplement, one with a low dose, and one with a high dose of Ensure Max Protein products. The goal is to determine if increased protein intake improves muscle mass in the arms and legs. The trial seeks individuals with heart failure who have experienced frequent hospitalizations or significant weight loss in the past year. As an unphased trial, it offers a unique opportunity to contribute to understanding the potential benefits of high-protein nutrition for heart failure patients.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify if you need to stop taking your current medications. However, you must be on guideline-directed medical therapy unless it's contraindicated or not tolerated.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that high-protein diets, such as those including Ensure Max Protein, are generally safe for people with heart failure. Studies indicate that increasing protein intake to about 1.5 grams per kilogram of body weight daily does not harm the kidneys in these patients. As a result, high-protein supplements are well-tolerated and may help prevent muscle loss.

Ensure Max Protein is designed to help build muscle, which is crucial for people with heart failure who often experience muscle loss. There have been no major reports of negative effects from using this type of protein supplement in people with heart failure, making it a promising option for those wanting to maintain muscle mass.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments because they focus on nutritional supplementation to address muscle wasting in heart failure patients, an area not typically emphasized by standard medications like ACE inhibitors or beta-blockers. Ensure Max Protein and Ensure Original differ in their protein content, providing 30 grams and 9 grams of protein per day, respectively, which could directly support muscle maintenance and growth. This approach is novel as it targets muscle wasting through dietary intervention rather than pharmacological means, offering a potentially safer and more accessible option for improving patient outcomes.

What evidence suggests that this trial's treatments could be effective for heart failure-related muscle wasting?

Research has shown that high-protein diets can help people with heart failure improve muscle mass and strength. In this trial, participants in the experimental arm will receive Ensure Max Protein, which studies have found boosts muscle protein, crucial for those who often lose muscle. This supplement may lead to small but meaningful improvements in muscle function. Participants in the sham comparator arm will receive Ensure Original, which offers lower protein supplementation. The protein in Ensure Max Protein could help prevent muscle loss by supporting muscle rebuilding. Overall, protein supplements may offer a promising way to address muscle loss in heart failure patients.12367

Are You a Good Fit for This Trial?

This trial is for adults aged 18-100 with heart failure and reduced ejection fraction (HFrEF), experiencing muscle wasting. They must be on standard heart failure treatments, have a left ventricular ejection fraction ≤40%, and show signs of severe heart failure like hospitalizations or significant weight loss. Excluded are pregnant women, those with certain muscle disorders, severe kidney issues, allergies to milk/protein/lactose intolerance/galactosemia, or very high body weight/BMI.

Inclusion Criteria

I am on standard treatment for my condition, unless I can't tolerate it.
I have had severe heart failure signs in the last year, like hospital stays or major weight loss.
My heart's pumping ability is reduced, and I have moderate to severe heart symptoms or high NT-proBNP levels.

Exclusion Criteria

You are allergic to milk or have trouble digesting milk sugar.
I weigh at least 350 pounds or my BMI is 40 or more.
I have a condition that causes muscle weakness or wasting.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive dietary protein supplementation with Ensure products, randomized between no, low, or high-dose groups

6 months
Monthly visits for assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Ensure Max Protein
  • Ensure Original
Trial Overview The study tests if different doses of dietary protein from Ensure(R) products can prevent muscle wasting in patients with HFrEF. Participants will be divided into three groups: one without protein supplementation, one with a low dose, and another with a high dose. The goal is to see if increased dietary protein affects muscle mass in the limbs.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental armExperimental Treatment1 Intervention
Group II: No intervention armActive Control1 Intervention
Group III: Sham comparator armActive Control1 Intervention

Ensure Max Protein is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Ensure for:
🇪🇺
Approved in European Union as Ensure for:
🇨🇦
Approved in Canada as Ensure for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Tufts Medical Center

Lead Sponsor

Trials
264
Recruited
264,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

In a study of 178 pre-frail older adults over 3 months, those who received leucine-enriched protein supplementation combined with exercise showed significant improvements in physical function, including gait speed and muscle strength, compared to those who only received nutrition support.
Both the nutrition with exercise and nutrition-only groups experienced reductions in inflammatory biomarkers IL-6 and TNF-α, indicating potential health benefits, although these improvements were not maintained after 6 months.
Impact of exercise and leucine-enriched protein supplementation on physical function, body composition, and inflammation in pre-frail older adults: a quasi-experimental study.Merchant, RA., Chan, YH., Anbarasan, D., et al.[2023]
Sarcopenia and muscle wasting are expected to increase in older adults due to COVID-19 hospitalizations and lockdowns, driven by factors like physical inactivity and poor diet.
Supplementing meals with whey protein-enriched enteral products, which provide 3-5 g of leucine, can effectively stimulate muscle protein synthesis in older adults, potentially helping to mitigate the risk of sarcopenia during prolonged periods of inactivity.
mTOR1c Activation with the Leucine "Trigger" for Prevention of Sarcopenia in Older Adults During Lockdown.Mai, K., Cando, P., Trasino, SE.[2022]
A specially-formulated composition of essential amino acids (HiEAA) significantly enhances protein synthesis in older individuals with heart failure compared to a popular protein-based meal replacement (LoEAA), with more than double the anabolic response (p < 0.001).
The HiEAA formulation not only suppresses protein breakdown more effectively (p < 0.001) but also offers a low-calorie option, making it beneficial for heart failure patients who often struggle with obesity.
Consumption of a Specially-Formulated Mixture of Essential Amino Acids Promotes Gain in Whole-Body Protein to a Greater Extent than a Complete Meal Replacement in Older Women with Heart Failure.Kim, IY., Park, S., Smeets, ETHC., et al.[2020]

Citations

A SkeleTal Muscle Recovery Intervention With Dietary ...This prospective randomized controlled trial will compare changes in the muscle mass in the arms and the legs (appendicular lean mass) in patients with HFrEF ...
High-Protein Nutrition for Heart Failure-related Muscle ...Ensure Max Protein could be a promising treatment because it helps increase muscle protein, which is important for people with heart failure who often lose ...
High-Protein Dietary Interventions in Heart FailureHigh-protein diets offer a promising nutritional intervention to improve these outcomes in individuals with HF. Objective: This systematic review evaluated ...
(PDF) High-Protein Dietary Interventions in Heart FailureConclusions: High-protein dietary strategies appear to confer modest, clinically relevant gains in functional capacity, nutritional status, and ...
Whey protein supplementation for the preservation of mass ...Whey protein supplementation may increase the effects of exercise on strength and muscle mass, in addition to promoting improved endothelial function, body ...
Nutrition Questions & AnswersBrowse our frequently asked nutrition questions to see what other consumers just like you are asking about nutrition. Visit Ensure.com for more!
Are high protein diets safe? | Abbott NewsroomIf you're on the go, you should know that drinking your protein is an option. Our Ensure Max Protein shakes, which have been featured by the ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security